Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5759580 | ALLERGAN | Compositions containing micronized nebivolol |
Jun, 2015
(8 years ago) | |
US6545040 | ALLERGAN | Method of lowering the blood pressure |
Dec, 2021
(2 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Chemical Entity Exclusivity(NCE) | Dec 17, 2012 |
NCE-1 date: 18 December, 2011
Market Authorisation Date: 17 December, 2007
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL